Candidate predisposing germline copy number variants in early onset colorectal cancer patients

Clin Transl Oncol. 2017 May;19(5):625-632. doi: 10.1007/s12094-016-1576-z. Epub 2016 Nov 25.

Abstract

Purpose: A great proportion of the heritability of colorectal cancer (CRC) still remains unexplained, and rare variants, as well as copy number changes, have been proposed as potential candidates to explain the so-called 'missing heritability'. We aimed to identify rare high-to-moderately penetrant copy number variants (CNVs) in patients suspected of having hereditary CRC due to an early onset.

Methods/patients: We have selected for genome-wide copy number analysis, 27 MMR-proficient early onset CRC patients (<50 years) without identifiable germline mutations in Mendelian genes related to this phenotype. Rare CNVs were selected by removing all CNVs detected at MAF >1% in the in-house control CNV database (n = 629 healthy controls). Copy number assignment was checked by duplex real-time quantitative PCR or multiplex ligation probe amplification. Somatic mutation analysis in candidate genes included: loss of heterozygosity studies, point mutation screening, and methylation status of the promoter.

Results: We have identified two rare germline deletions involving the AK3 and SLIT2 genes in two patients. The search for a second somatic mutational event in the corresponding CRC tumors showed loss of heterozygosity in AK3, and promoter hypermethylation in SLIT2. Both genes have been previously related to colorectal carcinogenesis.

Conclusions: These findings suggest that AK3 and SLIT2 may be potential candidates involved in genetic susceptibility to CRC.

Keywords: Copy number variants; Genetic susceptibility; Germline; Hereditary colorectal cancer.

MeSH terms

  • Age of Onset
  • Colorectal Neoplasms / genetics*
  • DNA Copy Number Variations / genetics*
  • DNA Methylation
  • DNA Mutational Analysis
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Genome-Wide Association Study
  • Humans
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Loss of Heterozygosity
  • Nerve Tissue Proteins / genetics*
  • Real-Time Polymerase Chain Reaction

Substances

  • Intercellular Signaling Peptides and Proteins
  • Nerve Tissue Proteins
  • Slit homolog 2 protein